# Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia

> **NCT00005935** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 130 (—)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Mycophenolate mofetil
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT00005935
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** 130 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005935, "Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*